Keywords: insmed, anti-tumor, agent, enters, clinic, usa, initiated

Insmed's anti-tumor agent enters clinic

Article | 20 September 2004

Print This

Insmed of the USA has initiated a Phase I clinical trial for itsanti-tumor agent, recombinant human Insulin-Like Growth Factor Binding ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in